Indacaterol Maleate
Cat.No:II1740 Solarbio
CAS:753498-25-8
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Endocrinology & Hormones >
Indacaterol MaleateCAS:753498-25-8
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 753498-25-8 |
Name | Indacaterol Maleate |
Molecular Formula | C28H32N2O7 |
Molecular Weight | 508.56 |
Solubility | Soluble in DMSO ≥10mg/mL |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD20526769 |
SMILES | CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O |
InChIKey | IREJFXIHXRZFER-PCBAQXHCSA-N |
InChI | InChI=1S/C24H28N2O3.C4H4O4/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24;5-3(6)1-2-4(7)8/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29);1-2H,(H,5,6)(H,7,8)/b;2-1-/t22-;/m0./s1 |
PubChem CID | 9827599 |
Target Point | Adrenergic Receptor |
Passage | Endocrinology & Hormones;GPCR & G Protein;Neuronal Signaling |
Background | It is a long-acting beta-adrenergic receptor agonist. |
Biological Activity | Indacaterol Maleate 是一种长效的β-肾上腺素受体激动剂,对β1-adrenoceptor的pKi为 7.36,对 β2-adrenoceptor 的pKi为5.48,可以用于治疗哮喘和慢性阻塞性肺病。[1] |
In Vitro | Indacaterol is close to a full agonist at the human beta(2)adrenoceptor(E(max)= 73 +/- 1% of the maximal effect of isoprenaline; pEC(50)= 8.06 +/- 0.02).[1] Indacaterol as a fast acting compound with a longer duration of action than salmeterol and formoterol.[2] Duration of action was determined against cholinergic neural contraction induced by electrical field stimulation(EFS). At resting tone,-logEC50 and Emax values were 8.82+/-0.41 and 77+/-5% for indacaterol. Indacaterol's onset of action(7.8+/-0.7 min) was significantly faster than that of salmeterol(19.4+/-4.3 min). EFS-induced contractions were inhibited with -logIC50 values of 6.96+/-0.13(indacaterol). Duration of action was >12 h for indacaterol and salmeterol.[3] Indacaterol is an effective inhibitor of the release of mediators from human lung mast cells. Indacaterol was as potent and as efficacious as the full agonist,isoprenaline(EC(50),approximately 4 nmol x L(-1)),at inhibiting the IgE-dependent release of histamine from mast cells.[4] In both the low- and high-expression recombinant GEVT 'wild type' cell lines indacaterol is a high-efficacy agonist. In the human primary ASM cells indacaterol gave a maximal response intermediate between that of salmeterol and formoterol.[5] |
In Vivo | In isolated superfused guinea pig trachea,indacaterol has a fast onset of action(30 +/- 4 min)and a long duration of action(529 +/- 99 min). In the conscious guinea pig,when given intratracheally as a dry powder,indacaterol inhibits 5-hydroxytryptamine-induced bronchoconstriction for at least 24 h,whereas salmeterol,formoterol,and salbutamol have durations of action of 12,4,and 2 h,respectively.[1] |
Data Literature Source | [1]. Battram C,et al. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol),a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. J Pharmacol Exp Ther. 2006 May;317(2):762-70. [2]. Sturton RG,et al. Pharmacological characterization of indacaterol,a novel once daily inhaled 2 adrenoceptor agonist,on small airways in human and rat precision-cut lung slices. J Pharmacol Exp Ther. 2008 Jan;324(1):270-5. [3]. Naline E,et al. Effect of indacaterol,a novel long-acting beta2-agonist,on isolated human bronchi. Eur Respir J. 2007 Mar;29(3):575-81. [4]. Scola AM,et al. The long-acting beta-adrenoceptor agonist,indacaterol,inhibits IgE-dependent responses of human lung mast cells. Br J Pharmacol. 2009 Sep;158(1):267-76. [5]. Sayers I,et al. Pharmacogenetic characterization of indacaterol,a novel beta 2-adrenoceptor agonist. Br J Pharmacol. 2009 Sep;158(1):277-86. |
Unit | Bottle |
Specification | 25mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.